Certified by Founder
Lodge
CatalYm GmbH
start up
Germany
- Martinsried, Bayern
- 16/07/2024
- Series D
- $150,000,000
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
- Industry Biotechnology Research
- Website https://www.catalym.com/
- LinkedIn https://www.linkedin.com/company/catalym/
Related People
Phil L'HuillierFounder
United Kingdom -
Greater London, England
Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)